Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites

<table>Epithelial scoring for CD74, HLA-DR, TAP-2, and CD48 expression and immunohistochemical staining in representative cases of low- and high-volume ascites associated primary tumor samples. Immunohistochemistry was performed on tissue microarrays containing a total of 54 tumors associated with high- and low-volume ascites. Magnification 9x.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites 